MNV
Market News Video
MNV MNV 10 Stocks Crossing Below Book Value
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

Thursday Sector Laggards: Healthcare, Utilities
Thursday, March 3, 2:31 PM ET, by Market News Video Staff

Looking at the sectors faring worst as of midday Thursday, shares of Healthcare companies are ...

Analysts See 14% Gains Ahead For IVV
Monday, March 7, 7:24 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Wednesday Sector Laggards: Healthcare, Financial
Wednesday, March 16, 2:42 PM ET, by Market News Video Staff

Looking at the sectors faring worst as of midday Wednesday, shares of Healthcare companies are ...

Tuesday Sector Leaders: Healthcare, Materials
Tuesday, March 22, 2:32 PM ET, by Market News Video Staff

In afternoon trading on Tuesday, Healthcare stocks are the best performing sector, up 1.2%. Within ...

Zoetis Takes Over #215 Spot From Vertex Pharmaceuticals
Wednesday, March 23, 4:40 PM ET, by Market News Video Staff

In the latest look at the underlying components of the S&P 500 ordered by largest ...

  More articles:  1 2 3 4 5 6 7 next »

CGEN Makes Bullish Cross Above Critical Moving Average

By Market News Video Staff, Tuesday, May 17, 1:27 PM ET
Play Video: Learn About The 200 DMA


If the video does not load after a few moments, Upgrade to the Latest Flash Player.

In trading on Tuesday, shares of Compugen Ltd (NASDAQ:CGEN) crossed above their 200 day moving average of $4.66, changing hands as high as $4.77 per share. Compugen Ltd shares are currently trading trading flat on the day. The chart below shows the one year performance of CGEN shares, versus its 200 day moving average:

Compugen Ltd 200 Day Moving Average Chart

Looking at the chart above, CGEN's low point in its 52 week range is $3.04 per share, with $5.80 as the 52 week high point that compares with a last trade of $4.56.

CGEN operates in the Biotechnology sector, among companies like Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX) which is down about 0.7% today, and Agilent Technologies, Inc. (NYSE:A) trading lower by about 2.6%. Below is a three month price history chart comparing the stock performance of CGEN, versus VRTX and A.

CGEN,VRTX,A Relative Performance Chart


Free Trial: ''ETF CHANNEL FLEXIBLE GROWTH INVESTMENT PORTFOLIO''

The ETF Channel Flexible Growth Investment Portfolio is designed to seek growth for investors anywhere and everywhere. The key to the program is our portfolio strategy allows us complete flexibility in terms of asset allocation as there are no predetermined guidelines as to the level of stocks, bonds, cash, regions, countries, sectors, commodities, or even asset classes in the portfolio! In short, this is a completely flexible portfolio designed to follow the performance trail wherever it leads us.


Top Six Most Viewed Stories This Week @ Market News Video:

This Article's Word Cloud:   Agilent   CGEN   Compugen   Crossing   Growth   Looking   Start   Stocks   Their   Trial   VRTX   about   above   allows   asset   average   below   changing   chart   commodities   compares   currently   designed   flexibility   follow   high   history   last   level   lower   month   moving   performance   point   portfolio   program   range   raquo   regions   sector   sectors   share   shares   that   trading   versus   week   wherever   which   with
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy - Video Widget
MNV
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Stock Message Boards Stock Market Definitions
MNV

CGEN Makes Bullish Cross Above Critical Moving Average | Market News Video | Copyright © 2008 - 2016, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.